IL143221A0 - Combination of cerivastatin and fibrates - Google Patents

Combination of cerivastatin and fibrates

Info

Publication number
IL143221A0
IL143221A0 IL14322199A IL14322199A IL143221A0 IL 143221 A0 IL143221 A0 IL 143221A0 IL 14322199 A IL14322199 A IL 14322199A IL 14322199 A IL14322199 A IL 14322199A IL 143221 A0 IL143221 A0 IL 143221A0
Authority
IL
Israel
Prior art keywords
fibrates
cerivastatin
combination
Prior art date
Application number
IL14322199A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL143221A0 publication Critical patent/IL143221A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
IL14322199A 1998-12-18 1999-12-06 Combination of cerivastatin and fibrates IL143221A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19858789A DE19858789A1 (de) 1998-12-18 1998-12-18 Kombination von Cerivastatin und Fibraten
PCT/EP1999/009524 WO2000037078A1 (de) 1998-12-18 1999-12-06 Kombination von cerivastatin und fibraten

Publications (1)

Publication Number Publication Date
IL143221A0 true IL143221A0 (en) 2002-04-21

Family

ID=7891784

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14322199A IL143221A0 (en) 1998-12-18 1999-12-06 Combination of cerivastatin and fibrates

Country Status (19)

Country Link
US (1) US6511985B1 (tr)
EP (1) EP1140082A1 (tr)
KR (1) KR20010093845A (tr)
CN (1) CN1330544A (tr)
AR (1) AR021643A1 (tr)
AU (1) AU3035600A (tr)
BR (1) BR9916270A (tr)
CA (1) CA2355295A1 (tr)
CO (1) CO5160272A1 (tr)
DE (1) DE19858789A1 (tr)
GT (1) GT199900214A (tr)
HN (1) HN1999000208A (tr)
IL (1) IL143221A0 (tr)
PE (1) PE20001325A1 (tr)
PL (1) PL349389A1 (tr)
SV (1) SV1999000250A (tr)
TR (1) TR200101722T2 (tr)
WO (1) WO2000037078A1 (tr)
ZA (1) ZA200103918B (tr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60129573T2 (de) 2000-09-20 2008-04-17 Jagotec Ag Verfahren zur sprühtrocknung von zusammensetzungen enthaltend fenofibrat
ATE357216T1 (de) * 2001-02-22 2007-04-15 Jagotec Ag Fibrat-statin kombinationen mit verminderten von der nahrungsaufnahme abhängigen auswirkungen
WO2003013608A1 (en) 2001-08-07 2003-02-20 Galephar M/F ORAL PHARMACEUTICAL COMPOSITION CONTAINING A COMBINAITION OF PPARα AND A HMG-COA REDUCTASE INHIBITOR
WO2003013607A1 (en) * 2001-08-07 2003-02-20 Galephar M/F ORAL PHARMACEUTICAL COMPOSITION CONTAINING A COMBINATION OF FENOFIBRATE AND A HMG-CoA REDUCTASE INHIBITOR
DE10200138A1 (de) * 2002-01-04 2003-07-17 Karl Winkler Kombination von einem PPAR-Agonisten mit PPAR-alpha Aktivität mit einem Induktor des LDL-Rezeptors
US7411045B2 (en) * 2002-11-19 2008-08-12 A&G Pharmaceutical, Inc. Autocrine growth factor receptor antibodies and methods
JP4901474B2 (ja) * 2003-05-30 2012-03-21 ランバクシー ラボラトリーズ リミテッド 置換ピロール誘導体
CA2543596A1 (en) * 2003-11-07 2005-05-26 Jj Pharma, Inc. Hdl-boosting combination therapy complexes
CA2597492A1 (en) * 2005-02-10 2006-08-17 Lifecycle Pharma A/S A stable pharmaceutical composition comprising a fixed dose combination of fenofibrate and an hmg-coa reductase inhibitor
AU2006313430B2 (en) * 2005-11-08 2012-09-06 Ranbaxy Laboratories Limited Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
WO2008020314A2 (en) * 2006-03-14 2008-02-21 Ranbaxy Laboratories Limited Statin stabilizing dosage formulations
US20070269503A1 (en) * 2006-05-16 2007-11-22 James Walter Burgess Combinations of HMG CoA reductase inhibitors and negatively charged phospholipids and uses thereof
AR063469A1 (es) * 2006-07-14 2009-01-28 Ranbaxy Lab Ltd Formas polimorficas de ácido (3r,5r)-7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]-pirrol-1-il]-3, 5-dihidroxi-heptanoico, sal hemicalcio, metodos de preparacion de las mismas, una composicion farmaceutica que las comprende y su uso en el tratamiento de enfermedades
CA2657394A1 (en) 2006-08-04 2008-02-07 Aska Pharmaceutical Co., Ltd. Preparation containing fibrate agent and process for producing the same
TWI407955B (zh) 2007-03-29 2013-09-11 Kowa Co 高脂血症之預防及／或治療劑
WO2023146320A1 (ko) * 2022-01-28 2023-08-03 동광제약 주식회사 로수바스타틴 또는 이의 약학적으로 허용되는 염 및 페노피브레이트를 함유하는 캡슐 제제

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2494112B1 (tr) 1980-11-19 1986-01-10 Laruelle Claude
WO1988005296A2 (en) 1987-01-27 1988-07-28 Warner-Lambert Company Lpid regulating compositions
FR2627696B1 (fr) 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
CA2039763A1 (en) * 1990-04-30 1991-10-31 Henry Y. Pan Combination of pravastatin and a fibric acid derivative, and method for treating dyslipidemia using such combination
US5177080A (en) 1990-12-14 1993-01-05 Bayer Aktiengesellschaft Substituted pyridyl-dihydroxy-heptenoic acid and its salts
FR2737121B1 (fr) 1995-07-27 1997-10-03 Cl Pharma Nouvelles formulations galeniques du fenofibrate et leurs applications
EP1792616B1 (en) * 1997-07-31 2009-12-16 Abbott Respiratory LLC Composition comprising an HMG-CoA inhibitor and a nicotinic acid compound for treating hyperlipidemia

Also Published As

Publication number Publication date
PL349389A1 (en) 2002-07-15
AR021643A1 (es) 2002-07-31
GT199900214A (es) 2001-06-08
HN1999000208A (es) 2000-11-22
TR200101722T2 (tr) 2001-11-21
CA2355295A1 (en) 2000-06-29
SV1999000250A (es) 2000-10-16
CO5160272A1 (es) 2002-05-30
AU3035600A (en) 2000-07-12
DE19858789A1 (de) 2000-06-21
ZA200103918B (en) 2002-05-15
PE20001325A1 (es) 2000-12-30
CN1330544A (zh) 2002-01-09
US6511985B1 (en) 2003-01-28
WO2000037078A1 (de) 2000-06-29
EP1140082A1 (de) 2001-10-10
KR20010093845A (ko) 2001-10-29
BR9916270A (pt) 2001-09-04

Similar Documents

Publication Publication Date Title
SG85628A1 (en) Compound and its use
IL183948A0 (en) Conjugates of peg-urate oxidase and use thereof
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
GB9813271D0 (en) Composition and use
PL333764A1 (en) Lamp and way of its operation
PL347357A1 (en) Novel composition and use
IL143221A0 (en) Combination of cerivastatin and fibrates
PL347689A1 (en) Absorbent product with arcuate longsides of end portion
PL343430A1 (en) Preparation and purification of diborane
EP1056455A4 (en) EPIMORPHIN COMPOUND AND USE OF THE SAME
GB9803232D0 (en) Compound composition and use
HUP0103309A3 (en) Novel salts of n-tert-butylhydroxylamine and preparation thereof
HK1042089A1 (zh) 氮雜環縮肽及其作為殺寄生蟲劑的用途
GB9807586D0 (en) Enzymes and their use
GB0118888D0 (en) Peak and/or trough detectors
GB9918174D0 (en) Disc covers and methods of manufacture thereof
EP1066051A4 (en) SCIELLIN AND ITS USE
GB9805172D0 (en) Composition and use
GB9802016D0 (en) Bootsac and coolsac
TW354479U (en) Improvement of earpick
GB9824867D0 (en) Novel composition and use
GB9824869D0 (en) Novel composition and use
GB9826250D0 (en) Novel composition and use
GB9824870D0 (en) Novel composition and use
GB9824866D0 (en) Novel composition and use